Aganirsen
- Generic Name
- Aganirsen
- Drug Type
- Biotech
- CAS Number
- 1146887-67-3
- Unique Ingredient Identifier
- 0N3FY8225K
- Background
Aganirsen is under investigation in clinical trial NCT02947867 (Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath